Physician

Jeffrey W Kanski, M.D.

According to 2025 Medicare claims, Jeffrey Kanski, M.D. (NPI: 1326044496) practices radiation oncology in the Port St. Lucie, FL market, with the plurality of this provider's patient population coming from St. Lucie, FL. This provider's primary affiliated billing organization is AQUA DERMATOLOGY OF FLORIDA, PA (NPI: 1538270335; TIN: 593651253) and primary practice location at 34947-5415.

Kanski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 264 traditional Medicare patients, billed 10,963 HCPCS/CPT codes, and received $1,661,869 in Medicare payments. The top billing code was 77290 (Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved). Part D data shows 174 prescription claims across 130 beneficiaries totaling $1,287 in drug costs, led by Mupirocin (Mupirocin). Open Payments data shows 1 records totaling $16. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $6,708 to $1,287. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	81	1,959	$294,748
2016	276	6,779	$1,074,042
2017	239	10,521	$1,688,290
2018	192	9,125	$1,567,147
2019	190	7,759	$1,342,714
2020	223	9,113	$1,572,651
2021	204	8,414	$1,483,705
2022	200	7,863	$1,307,608
2023	244	9,414	$1,485,803
2024	264	10,963	$1,661,869

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	49	108	$6,708
2016	54	83	$2,257
2017	63	69	$725
2018	64	81	$890
2019	92	100	$1,102
2020	105	137	$1,195
2021	134	196	$1,592
2022	93	129	$1,415
2023	156	195	$1,638
2024	130	174	$1,287

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
77290	Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved	185	507	$337
G6012	Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev	184	5,309	$174
77334	Design and construction of complex radiation treatment device	185	1,634	$97
77336	Continuing radiation therapy consultation per week	182	1,021	$69
77300	Calculation of radiation therapy dose	186	526	$51

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mupirocin	Mupirocin	139	2,498	$1,017
Silver Sulfadiazine	Silver Sulfadiazine	14	321	$67

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$16	Verrica Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey W. Kanski, M.D.?

Tedicare shows public-source Medicare data for Jeffrey W. Kanski, M.D. (NPI 1326044496), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey W. Kanski, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffrey W. Kanski, M.D.?

Jeffrey W. Kanski, M.D. is linked to AQUA DERMATOLOGY OF FLORIDA, PA (billing NPI 1538270335) in the available physician profile data.

Does Jeffrey W. Kanski, M.D. have Open Payments data?

Jeffrey W. Kanski, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.